Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
变构抑制可增强 ABL 激酶抑制剂靶向未突变 BCR-ABL 和 BCR-ABL-T315I 的疗效。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/1471-2407-12-411
Mian, Afsar Ali; Metodieva, Anna; Badura, Susanne; Khateb, Mamduh; Ruimi, Nili; Najajreh, Yousef; Ottmann, Oliver Gerhard; Mahajna, Jamal; Ruthardt, Martin